OMICS Group Aims to Apply Vital Responsibility in Pharmaceutical Industry by Regulatory Affairs 2014

OMICS Group International announces the commencement of the 4th International Conference on Pharmaceutical Regulatory Affairs on September 08-10, 2014 in Raleigh, USA, focusing on “Key implications in Regulatory Environment”.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This

Key Implications in Regulatory Environment

Henderson, NV (PRWEB) April 14, 2014

Regulatory Affairs-2014 is going to mark the presence of professionals from Regulatory affairs, Quality and manufacturing, Clinical development, Regulatory authorities, Business and marketing wings in the pharmaceutical sector.

Major highlights of this OMICS Group scientific conferences includes current regulatory aspects like API (Active Pharmaceutical Ingredients), scheduled drugs, over the counter drugs, subsequent process validation, audit process and inspection, common technical document, NDA (New Drug Application) and ANDA (Abbreviated New Drug Application) providing an up to date and in-depth information on the present scenario of the Pharmaceutical regulatory world. OMICS Group Regulatory Affairs-2014 has been exceptionally formulated with comprehensive scientific program including effectual keynote presentations, session-wise talks, poster presentations, special workshops and symposiums on contemporary pharmaceutical design controls which would lead for further advancements and technological innovations in regulatory affairs industry.

OMICS Group Open Access Journals publishes 350 online, peer reviewed science journals in the fields of Clinical, Medical, Engineering and technological, Pharmaceutical and Management fields also organizes more than 100 international science conferences and events across the globe. With the help of more than 150 scientific associations with the likeminded organization, the publisher is contributing for the dissemination of scientific knowledge and information.

This Pharmaceutical Conference promises wide ranging opportunities for prominent people to share their research ideas by gathering all them under the same roof. OMICS Group also includes opportunities for sponsors, exhibitors and media partners through collaborating, interacting and promoting their products and services. Regulatory Affairs-2014 Organizing Committee will also host Young Researchers Forum which will provide young researchers with the possibility to meet and discuss research topics and methodologies.

Organizing Committee Members of the Regulatory Affairs-2014 includes: Michael Drues, USA; Najy Alsayed, Switzerland; Dr. Vladimir V Popov, Russia; Mamoona Firdous Naqvi, UAE; Stephan Hall, LLC; Dallas Thomas, USA ; Ramak Pidapathi, USA; Shivananda puthli, India.

OMICS Group also aims at delivering unlimited B2B opportunities for making business deals, product enhancements, cutting edge solutions for improving and elevating company's business and partnership with an insight to unite all the leading industry professionals, business development executives, institutional investors, capitalists and corporate investors. This enables in arranging private One-to-One meetings with other elite business representatives thereby providing access to global business community. B2B meeting will encourage the business ideas of respected participants by one to one meet by their own experiences.

For more details on Regulatory Affairs -2014 conference, please visit: http://regulatoryaffairs2014.pharmaceuticalconferences.com/.

For further details, contact:
Kasper Dave
Regulatory Affairs -2014 Organizing Committee
Pharmaceutical Conferences
5716 Corsa Ave, Suite110
Westlake, Los Angeles
CA-91362-7354, USA
Phone: +1-650-268-9744
Fax: +1-650-618-1414
Toll No: +1-800-216-6499
E-mail: regulatoryaffairs2014 (at) omicsgroup (dot) us


Contact

Follow us on: Contact's Google Plus

Attachments